|
US4668685A
(en)
|
1984-07-05 |
1987-05-26 |
E.I. Du Pont De Nemours And Company |
Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
|
|
EP0615756B1
(en)
*
|
1993-03-15 |
2001-06-27 |
National Science Council |
Nalbuphine esters and long-acting pharmaceutical compositions containing them
|
|
CN1050130C
(zh)
|
1997-07-04 |
2000-03-08 |
卢正堂 |
纳洛酮酸脂和纳屈酮酸脂及系列物和制备方法
|
|
ES2188481T3
(es)
|
2000-04-27 |
2003-07-01 |
Oliver Yoa-Pu Hu |
Derivados de polinalbufina.
|
|
TWI226239B
(en)
|
2000-05-15 |
2005-01-11 |
You-Pu Hu |
Novel oral pharmaceutical composition containing nalbuphine ester prodrug
|
|
CA2771263A1
(en)
|
2000-07-27 |
2002-02-07 |
Rutgers, The State University |
Therapeutic polyesters and polyamides
|
|
US6569449B1
(en)
*
|
2000-11-13 |
2003-05-27 |
University Of Kentucky Research Foundation |
Transdermal delivery of opioid antagonist prodrugs
|
|
US20040033253A1
(en)
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
|
US7759358B2
(en)
|
2003-07-23 |
2010-07-20 |
Crooks Peter A |
Oral bioavailable prodrugs
|
|
US20050137141A1
(en)
|
2003-10-24 |
2005-06-23 |
John Hilfinger |
Prodrug composition
|
|
EP1928881A2
(en)
|
2005-08-19 |
2008-06-11 |
Pharmacofore, Inc. |
Prodrugs of active agents
|
|
US20090186832A1
(en)
|
2008-01-18 |
2009-07-23 |
Shire Llc |
Amino acid peptide pro-drugs of phenolic analgesics and uses thereof
|
|
EP2413937A1
(en)
|
2009-04-02 |
2012-02-08 |
Shire LLC |
Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
|
|
AU2010272233A1
(en)
|
2009-07-17 |
2012-02-09 |
Shire Llc |
Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof
|
|
EP2628489B1
(en)
*
|
2009-07-21 |
2017-03-01 |
Nektar Therapeutics |
PEG oligomer-fentanyl conjugates
|
|
US20110190267A1
(en)
*
|
2010-01-05 |
2011-08-04 |
Shire Pharmaceuticals, Inc. |
Prodrugs of opioids and uses thereof
|
|
US8461171B2
(en)
*
|
2010-02-09 |
2013-06-11 |
QRxPharma Ltd. |
Hybrid opioid compounds and compositions
|
|
EP2552924B1
(en)
*
|
2010-04-02 |
2015-09-16 |
Zynerba Pharmaceuticals, Inc. |
Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs
|
|
AR084620A1
(es)
*
|
2010-12-28 |
2013-05-29 |
Euro Celtique Sa |
Una combinacion de un agonista opiaceo y un antagonista opiaceo en el tratamiento de la enfermedad de parkinson
|
|
US10017519B2
(en)
*
|
2015-04-27 |
2018-07-10 |
3St Research Llc |
Alpha-hydroxy carboxylic acid and derivatives and other GRAS based prodrugs of oxycodone and uses thereof
|
|
US9987269B2
(en)
*
|
2015-04-27 |
2018-06-05 |
3St Research Llc |
Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of oxymorphone and uses thereof
|
|
US10449190B2
(en)
*
|
2015-04-27 |
2019-10-22 |
John K. Thottathil |
Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of opioids and uses thereof
|
|
US9974858B2
(en)
*
|
2015-08-29 |
2018-05-22 |
Medrx Co., Ltd |
Percutaneous absorption composition
|
|
US12590065B2
(en)
*
|
2017-04-14 |
2026-03-31 |
Zevra Therapeutics, Inc. |
Levorphanol prodrugs and processes for making and using them
|
|
US11186585B2
(en)
*
|
2018-08-17 |
2021-11-30 |
Kappa-Pharma LLC |
Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates
|